Skip to main content
All lobbying filings

ARNOLD & PORTER KAYE SCHOLER LLP

Lobbying for EXELIXIS, INC. · Oncology-focused biotechnology company

 Filing 2nd Quarter - Report
2nd Quarter (Apr 1 - June 30) 2026 · California · House · Senate · $60,000.00 income · posted Jul 20, 2026

Official filing document

 Bills named in this filing 2
 Lobbying activity 2
Health Issues

Issues related to access, coverage, and payment for cancer drugs. Issues regarding the 340B program.

Medicare/Medicaid

Issues related to access, coverage, and payment for cancer drugs. Issues regarding the Inflation Reduction Act (P.L. No. 117-169), including implementation and the small biotech exception. Issues related to the Small Biotech Innovation Act (S. 1930 / H.R. 3731).

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem